Yonehara Michiko, Nakagawa Yuji, Ayatsuka Yuji, Hara Yuko, Shoji Jun, Ebihara Nobuyuki, Inomata Takenori, Huang Tianxiang, Nagino Ken, Fukuda Ken, Kishimoto Tatsuma, Sumi Tamaki, Fukushima Atsuki, Fujishima Hiroshi, Kawai Moeko, Takamura Etsuko, Uchio Eiichi, Namba Kenichi, Koyama Ayumi, Haruki Tomoko, Sasaki Shin-Ich, Shimizu Yumiko, Miyazaki Dai
Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan.
Technology Laboratory, Cresco Ltd., Tokyo, Japan.
Allergol Int. 2025 Jan;74(1):86-96. doi: 10.1016/j.alit.2024.07.004. Epub 2024 Aug 17.
Artificial intelligence (AI) is a promising new technology that has the potential of diagnosing allergic conjunctival diseases (ACDs). However, its development is slowed by the absence of a tailored image database and explainable AI models. Thus, the purpose of this study was to develop an explainable AI model that can not only diagnose ACDs but also present the basis for the diagnosis.
A dataset of 4942 slit-lamp images from 10 ophthalmological institutions across Japan were used as the image database. A sequential pipeline of segmentation AI was constructed to identify 12 clinical findings in 1038 images of seasonal and perennial allergic conjunctivitis (AC), atopic keratoconjunctivitis (AKC), vernal keratoconjunctivitis (VKC), giant papillary conjunctivitis (GPC), and normal subjects. The performance of the pipeline was evaluated by determining its ability to obtain explainable results through the extraction of the findings. Its diagnostic accuracy was determined for 4 severity-based diagnosis classification of AC, AKC/VKC, GPC, and normal.
Segmentation AI pipeline efficiently extracted crucial ACD indicators including conjunctival hyperemia, giant papillae, and shield ulcer, and offered interpretable insights. The AI pipeline diagnosis had a high diagnostic accuracy of 86.2%, and that of the board-certified ophthalmologists was 60.0%. The pipeline had a high classification performance, and the area under the curve (AUC) was 0.959 for AC, 0.905 for normal subjects, 0.847 for GPC, 0.829 for VKC, and 0.790 for AKC.
An explainable AI model created by a comprehensive image database can be used for diagnosing ACDs with high degree of accuracy.
人工智能(AI)是一项很有前景的新技术,有潜力用于诊断变应性结膜疾病(ACD)。然而,由于缺乏量身定制的图像数据库和可解释的人工智能模型,其发展受到了阻碍。因此,本研究的目的是开发一种不仅能诊断ACD,还能提供诊断依据的可解释人工智能模型。
来自日本10家眼科机构的4942张裂隙灯图像数据集被用作图像数据库。构建了一个分割人工智能的顺序管道来识别季节性和常年性变应性结膜炎(AC)、特应性角结膜炎(AKC)、春季角结膜炎(VKC)、巨大乳头性结膜炎(GPC)和正常受试者的1038张图像中的12项临床特征。通过确定其通过提取特征获得可解释结果的能力来评估该管道的性能。针对AC、AKC/VKC、GPC和正常的4种基于严重程度的诊断分类确定其诊断准确性。
分割人工智能管道有效地提取了包括结膜充血、巨大乳头和盾形溃疡在内的关键ACD指标,并提供了可解释的见解。人工智能管道诊断的诊断准确性高达86.2%,而获得委员会认证的眼科医生的诊断准确性为60.0%。该管道具有较高的分类性能,曲线下面积(AUC)对于AC为0.959,对于正常受试者为0.905,对于GPC为0.847,对于VKC为0.829,对于AKC为0.790。
由综合图像数据库创建的可解释人工智能模型可用于高度准确地诊断ACD。